Tizanidine Induced Hypotension : Report of a Case and Review of the Literature
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
INTRODUCTION: Spasticity is a common sequelae of stroke, and often these patients receive anti-spastic drugs such as baclofen or tizanidine. Stroke patients have multiple co-morbidities such as hypertension, diabetes, and seizure. Tizanidine is an α2 and imidazole receptor agonist at a spinal and supraspinal level resulting in reduced central sympathetic outflow and causing hypotension rarely, especially in those receiving beta-blockers or angiotensin-converting enzyme inhibitors.
CASE PRESENTATION: We report a 56-year-old hypertensive male presenting with altered sensorium who had recurrent intracerebral hemorrhage with left spastic hemiplegia and focal seizures. He was on amlodipine, atenolol, telmisartan and oxcarbazepine. After 3 doses of tizanidine 2mg, his blood pressure dropped from 140/90 to 80/40 mmHg and pulse from 82 bpm to 44 bpm. His blood counts, serum chemistry, procalcitonin, and Trop I were normal. ECG revealed sinus bradycardia. After 8 hours of withdrawing tizanidine, his blood pressure became 110/70 mmHg, and on the next day, it became 140/82 mmHg. His attendants were taught physiotherapy to minimize spasticity.
CONCLUSION: This patient highlights the need for close monitoring of patients receiving tizanidine co-medication with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. These drugs have a synergistic effect on reducing the renin-angiotensin-aldosterone system, thereby hypotension and bradycardia.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:19 |
---|---|
Enthalten in: |
Current drug safety - 19(2024), 2 vom: 23., Seite 313-316 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mahajan, Roopali [VerfasserIn] |
---|
Links: |
---|
Themen: |
6AI06C00GW |
---|
Anmerkungen: |
Date Completed 10.01.2024 Date Revised 10.01.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.2174/1574886318666230725113855 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM359899870 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM359899870 | ||
003 | DE-627 | ||
005 | 20240114233338.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/1574886318666230725113855 |2 doi | |
028 | 5 | 2 | |a pubmed24n1255.xml |
035 | |a (DE-627)NLM359899870 | ||
035 | |a (NLM)37489780 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mahajan, Roopali |e verfasserin |4 aut | |
245 | 1 | 0 | |a Tizanidine Induced Hypotension |b Report of a Case and Review of the Literature |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.01.2024 | ||
500 | |a Date Revised 10.01.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a INTRODUCTION: Spasticity is a common sequelae of stroke, and often these patients receive anti-spastic drugs such as baclofen or tizanidine. Stroke patients have multiple co-morbidities such as hypertension, diabetes, and seizure. Tizanidine is an α2 and imidazole receptor agonist at a spinal and supraspinal level resulting in reduced central sympathetic outflow and causing hypotension rarely, especially in those receiving beta-blockers or angiotensin-converting enzyme inhibitors | ||
520 | |a CASE PRESENTATION: We report a 56-year-old hypertensive male presenting with altered sensorium who had recurrent intracerebral hemorrhage with left spastic hemiplegia and focal seizures. He was on amlodipine, atenolol, telmisartan and oxcarbazepine. After 3 doses of tizanidine 2mg, his blood pressure dropped from 140/90 to 80/40 mmHg and pulse from 82 bpm to 44 bpm. His blood counts, serum chemistry, procalcitonin, and Trop I were normal. ECG revealed sinus bradycardia. After 8 hours of withdrawing tizanidine, his blood pressure became 110/70 mmHg, and on the next day, it became 140/82 mmHg. His attendants were taught physiotherapy to minimize spasticity | ||
520 | |a CONCLUSION: This patient highlights the need for close monitoring of patients receiving tizanidine co-medication with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. These drugs have a synergistic effect on reducing the renin-angiotensin-aldosterone system, thereby hypotension and bradycardia | ||
650 | 4 | |a Review | |
650 | 4 | |a Case Reports | |
650 | 4 | |a Spasticity | |
650 | 4 | |a angiotensin-converting enzyme inhibitors. | |
650 | 4 | |a bradycardia | |
650 | 4 | |a hypotension | |
650 | 4 | |a stroke | |
650 | 4 | |a tizanidine | |
650 | 7 | |a tizanidine |2 NLM | |
650 | 7 | |a 6AI06C00GW |2 NLM | |
650 | 7 | |a Angiotensin-Converting Enzyme Inhibitors |2 NLM | |
700 | 1 | |a Kalita, Jayantee |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current drug safety |d 2006 |g 19(2024), 2 vom: 23., Seite 313-316 |w (DE-627)NLM181475790 |x 2212-3911 |7 nnns |
773 | 1 | 8 | |g volume:19 |g year:2024 |g number:2 |g day:23 |g pages:313-316 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/1574886318666230725113855 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 19 |j 2024 |e 2 |b 23 |h 313-316 |